ESLA

Estrella Immunopharma

1.360

+0.310+29.52%

After Hours: 1.340 -0.020 -1.47%19:43 04/06 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.080/1.050

TODAY RANGE1.070-1.450

VOL694.59K

MARKET CAP58.02M

52 WEEK RANGE0.7800-3.150

AVG VOL (3M)184.96K

% TURNOVER1.63%

TURNOVER--

P/E (TTM)-3.8331

% RANGE40.00%

EPS(TTM)-0.3548

P/E(FORWARD)-3.8857

P/B-4.9817

BVPS-0.2730

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP22.55M

SHARES OUTSTANDING42.67M

NEXT EARNINGS05/12-05/18

FREE FLOAT16.58M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Reuters·03/23 12:03
Zacks Small-Cap Research initiates coverage of Estrella Immunopharma with $12/share valuation
Reuters·03/18 10:03
Estrella Immunopharma FY 2025 net loss widened 48.86% to USD 13.1 million
Dow Jones·02/09 12:40
Estrella Immunopharma Is Maintained at Buy by D. Boral Capital
Dow Jones·02/09 12:40
Estrella Immunopharma Price Target Maintained With a $8.00/Share by D. Boral Capital
TipRanks·02/09 12:21
Estrella Immunopharma presents updated data on EB103
Reuters·02/09 12:01
Estrella Immunopharma Reports 100% Complete Response Rate for EB103 in Phase I B-cell NHL Trial
Reuters·02/03 13:02
Estrella Immunopharma Unveils Phase 1 STARLIGHT-1 Data for EB103 in Aggressive B-Cell Lymphoma
Reuters·02/03 13:00
ESTRELLA IMMUNOPHARMA ANNOUNCES LATE-BREAKING ORAL PRESENTATION OF PHASE 1 STARLIGHT-1 DATA FOR EB103 AT THE 2026 TANDEM MEETINGS OF ASTCT® & CIBMTR®
Dow Jones·01/28 12:14
Estrella Immunopharma Is Maintained at Buy by D. Boral Capital
Dow Jones·01/28 12:14
Estrella Immunopharma Price Target Cut to $8.00/Share From $16.00 by D. Boral Capital
TipRanks·01/13 22:48
Estrella Immunopharma Receives Nasdaq Non-Compliance Notice
Reuters·01/13 22:22
Estrella Immunopharma Faces Nasdaq Delisting Risk Over Missed Annual Meeting
TipRanks·01/06 21:40
Estrella Immunopharma completes $8M direct offering financing
Reuters·01/06 19:02
Estrella Immunopharma Closes $8 Million Offering With Issuance of Shares and Warrants
Reuters·01/06 19:02
ESTRELLA IMMUNOPHARMA ANNOUNCES CLOSING OF $8.0 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT

Same Industry

Name/Symbol

Change%

Price

Regeneron Pharmaceuticals

REGN

-1.98%

761.85

GridAI Tech

GRDX

-3.63%

2.390

BNTX

United Therapeutics Corp.

UTHR

-0.96%

564.81

VRTX

SIGA

MRNA

CRL

MEDP

Talphera Inc

TLPH

-7.12%

0.7223

ICLR

CBPO

IQV

MOLN

Arcturus Therape

ARCT

+2.29%

8.03

Gilead Sciences Inc

GILD

+0.30%

140.13

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.